The 2-DG was developed by the Institute of Nuclear Medicine and Allied Sciences, a lab of DRDO, in collaboration with Dr. Reddy’s Laboratories.
from The Hindu - National https://ift.tt/3cqdTUo
via alochona
Wednesday, June 9, 2021
Home »
» DRDO invites EoI to transfer technology of 2-DG drug for bulk production
0 comments:
Post a Comment